Becker's Healthcare January 16, 2025
Rylee Wilson

Optum Rx will pass 100% of the rebates it negotiates for drugs onto its consumers by the end of 2028, UnitedHealth Group CEO Andrew Witty told investors.

On the company’s fourth-quarter earnings call on Jan. 16, Mr. Witty told investors most of the pharmaceutical benefit manager’s clients choose plans where they receive the full amount of rebates. A few choose other models.

“We are committed to fully phasing out those arrangements so that 100% of rebates will go to customers by 2028 at the latest. We will continue to encourage all of our clients to fully pass these savings directly to patients at the point of sale, as we already do for all of the people we serve in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech
Patients, clinics grapple with unintended consequence of lower drug prices
Prescription drug cap may save Medicare enrollees thousands: Report
UnitedHealth Group CEO: Value-Based Care Could Offset Rising Provider, Drug Costs
JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson
Insulin prices at 10-year low: GoodRx

Share This Article